Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;21(6):828-851.
doi: 10.2174/1567201820666230223085403.

Nanomaterials as a Potential Target for Infectious Parasitic Agents

Rawan H Alsharedeh  1 , Meriem Rezigue  1 , Rasha M Bashatwah  1 , Haneen Amawi  2 , Alaa A A Aljabali  1 , Mohammad A Obeid  1 , Murtaza M Tambuwala  3
Affiliations
Review

Nanomaterials as a Potential Target for Infectious Parasitic Agents

Rawan H Alsharedeh et al. Curr Drug Deliv. 2024.

Abstract

Despite the technological advancement in the era of personalized medicine and therapeutics development, infectious parasitic causative agents remain one of the most challenging areas of research and development. The disadvantages of conventional parasitic prevention and control are the emergence of multiple drug resistance as well as the non-specific targeting of intracellular parasites, which results in high dose concentration needs and subsequently intolerable cytotoxicity. Nanotechnology has attracted extensive interest to reduce medication therapy adverse effects including poor bioavailability and drug selectivity. Numerous nanomaterials-based delivery systems have previously been shown in animal models to be effective in the treatment of various parasitic infections. This review discusses a variety of nanomaterials-based antiparasitic procedures and techniques as well as the processes that allow them to be targeted to different parasitic infections. This review focuses on the key prerequisites for creating novel nanotechnology-based carriers as a potential option in parasite management, specifically in the context of human-related pathogenic parasitic agents.

Keywords: Parasites; antimicrobial.; drug delivery; infections; nanomaterials; nanoparticles.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Date A.; Joshi M.; Patravale V.; Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 2007,59(6),505-521 - DOI - PubMed
    1. Zazo H.; Colino C.I.; Lanao J.M.; Current applications of nanoparticles in infectious diseases. J Control Release 2016,224,86-102 - DOI - PubMed
    1. Ma J.Y.; Li M.Y.; Qi Z.Z.; Fu M.; Sun T.F.; Elsheikha H.M.; Cong W.; Waterborne protozoan outbreaks: An update on the global, regional, and national prevalence from 2017 to 2020 and sources of contamination. Sci Total Environ 2022,806(2),150562 - DOI - PubMed
    1. Pensel P.E.; Ullio Gamboa G.; Fabbri J.; Ceballos L.; Sanchez Bruni S.; Alvarez L.I.; Allemandi D.; Benoit J.P.; Palma S.D.; Elissondo M.C.; Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop 2015,152,185-194 - DOI - PubMed
    1. Amini S.M.; Preparation of antimicrobial metallic nanoparticles with bioactive compounds. Mater Sci Eng C 2019,103,109809 - DOI - PubMed

MeSH terms

Grants and funding